CN114369643A - Cell-free DNA detection kit, detection system and operation method - Google Patents
Cell-free DNA detection kit, detection system and operation method Download PDFInfo
- Publication number
- CN114369643A CN114369643A CN202210042210.1A CN202210042210A CN114369643A CN 114369643 A CN114369643 A CN 114369643A CN 202210042210 A CN202210042210 A CN 202210042210A CN 114369643 A CN114369643 A CN 114369643A
- Authority
- CN
- China
- Prior art keywords
- dna
- free dna
- cell
- kit
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 61
- 238000000034 method Methods 0.000 title claims abstract description 16
- 108020004414 DNA Proteins 0.000 claims abstract description 86
- 239000000017 hydrogel Substances 0.000 claims abstract description 41
- 108091027757 Deoxyribozyme Proteins 0.000 claims abstract description 34
- 239000003298 DNA probe Substances 0.000 claims abstract description 18
- 108020003215 DNA Probes Proteins 0.000 claims abstract description 16
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims abstract description 16
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims abstract description 16
- 102000003960 Ligases Human genes 0.000 claims abstract description 15
- 108090000364 Ligases Proteins 0.000 claims abstract description 15
- 239000005549 deoxyribonucleoside Substances 0.000 claims abstract description 12
- 235000011178 triphosphate Nutrition 0.000 claims abstract description 12
- 239000001226 triphosphate Substances 0.000 claims abstract description 12
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 15
- 238000012545 processing Methods 0.000 claims description 14
- 238000010146 3D printing Methods 0.000 claims description 12
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 claims description 11
- 150000003278 haem Chemical class 0.000 claims description 11
- 238000012258 culturing Methods 0.000 claims description 6
- 239000007853 buffer solution Substances 0.000 claims description 5
- 238000011534 incubation Methods 0.000 claims description 5
- 239000003086 colorant Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000006555 catalytic reaction Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 239000008055 phosphate buffer solution Substances 0.000 claims 2
- 238000005286 illumination Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 12
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000003321 amplification Effects 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 238000011304 droplet digital PCR Methods 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108091081406 G-quadruplex Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 101150063858 Pik3ca gene Proteins 0.000 description 1
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007846 asymmetric PCR Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000000104 diagnostic biomarker Substances 0.000 description 1
- 238000007847 digital PCR Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000003891 environmental analysis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/682—Signal amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及肿瘤智能检测技术领域,尤其涉及一种细胞游离DNA检测试剂盒、检测系统及操作方法。The invention relates to the technical field of intelligent tumor detection, in particular to a cell-free DNA detection kit, a detection system and an operation method.
背景技术Background technique
在过去的几十年里,DNA水凝胶由于其精确的可编程性、稳定性和生物相容性,在药物释放、组织工程、环境分析、生物传感等领域得到了广泛应用,特别是由纯DNA组成的纯DNA水凝胶,引起了广泛的关注。纯DNA水凝胶的构建一般是通过DNA片段的自组装或酶扩增,因此纯DNA水凝胶比DNA杂交水凝胶具有易于合成的优势。In the past few decades, DNA hydrogels have been widely used in drug release, tissue engineering, environmental analysis, biosensing and other fields due to their precise programmability, stability and biocompatibility, especially Pure DNA hydrogels composed of pure DNA have attracted extensive attention. The construction of pure DNA hydrogels is generally through self-assembly or enzymatic amplification of DNA fragments, so pure DNA hydrogels have the advantage of being easier to synthesize than DNA hybrid hydrogels.
细胞游离DNA(cell-free DNA,cfDNA)是一种典型的DNA片段,作为一种无创诊断生物标志物引起了人们的广泛关注。此外,细胞游离DNA在生物医学诊断中发挥着重要作用,如早期诊断癌症、评估肿瘤分期、选择有效治疗方案、监测预后等。基于聚合酶链反应(PCR)的方法如液滴数字PCR(ddPCR)、不对称PCR、乳剂数字PCR和反转录定量PCR(RT-qPCR)被认为是细胞游离DNA检测的金标准。此外,近年来还建立了电化学、串珠、乳化液、扩增和磁性平台以及扩增难变异系统(ARMS)等检测方法,以提高细胞游离DNA分析的性能。虽然这些测试方法很有前途,但它们仍然需要依靠精密仪器,不能满足便携式检测的需要,以致不能得到更广泛的应用。因此,针对资源相对匮乏的农村,开发一个无需仪器的、可视化的细胞游离DNA检测平台是十分必要的。Cell-free DNA (cfDNA), a typical DNA fragment, has attracted widespread attention as a non-invasive diagnostic biomarker. In addition, cell-free DNA plays an important role in biomedical diagnosis, such as early diagnosis of cancer, assessment of tumor stage, selection of effective treatment options, monitoring of prognosis, etc. Polymerase chain reaction (PCR)-based methods such as droplet digital PCR (ddPCR), asymmetric PCR, emulsion digital PCR, and reverse transcription quantitative PCR (RT-qPCR) are considered the gold standard for cell-free DNA detection. In addition, detection methods such as electrochemistry, beading, emulsion, amplification and magnetic platforms, and Amplification Refractory Mutation System (ARMS) have been established in recent years to improve the performance of cell-free DNA analysis. Although these test methods are promising, they still rely on sophisticated instruments and cannot meet the needs of portable detection, so that they cannot be used more widely. Therefore, it is very necessary to develop an instrument-free and visualized cell-free DNA detection platform for rural areas with relatively scarce resources.
迄今为止,智能手机作为光学定量仪器,凭借其强大的成像硬件、内置传感系统和先进的软件设计等功能,在生物医学、生物分析、环境监测等领域得到了广泛的应用。So far, smartphones, as optical quantitative instruments, have been widely used in biomedicine, biological analysis, environmental monitoring, and other fields by virtue of their powerful imaging hardware, built-in sensing systems, and advanced software design.
发明内容SUMMARY OF THE INVENTION
有鉴于此,本发明的目的在于提出一种细胞游离DNA检测试剂盒、检测系统及操作方法,能够快捷方便且灵敏地检测人血清中细胞游离DNA。In view of this, the purpose of the present invention is to provide a cell-free DNA detection kit, detection system and operation method, which can quickly, conveniently and sensitively detect cell-free DNA in human serum.
基于上述目的,本发明提供了一种细胞游离DNA检测试剂盒,包括锁式DNA探针、T4连接酶、phi29 DNA聚合酶和脱氧核糖核苷三磷酸;或由细胞游离DNA、锁式DNA探针、T4连接酶、phi29 DNA聚合酶和脱氧核糖核苷三磷酸形成的DNAzyme水凝胶;所述锁式DNA探针的序列如SEQ ID NO.1所示。Based on the above purpose, the present invention provides a cell-free DNA detection kit, comprising a padlock DNA probe, T4 ligase, phi29 DNA polymerase and deoxyribonucleoside triphosphate; or a cell-free DNA, padlock DNA probe A DNAzyme hydrogel formed by needle, T4 ligase, phi29 DNA polymerase and deoxyribonucleoside triphosphate; the sequence of the padlock DNA probe is shown in SEQ ID NO.1.
SEQ ID NO.1所示的锁式DNA探针的序列为:The sequence of the padlock DNA probe shown in SEQ ID NO.1 is:
5’-phosphorylated-TTAGAGAGTATTTTTTTTTTTCCCCCTTTTTTCAGTGATT-3’5’-phosphorylated-TTAGAGAGTATTTTTTTTTTTCCCCCTTTTTCAGTGATT-3’
作为一种可选的实施方式,所述DNAzyme水凝胶的制备方法包括如下步骤:As a kind of optional embodiment, the preparation method of described DNAzyme hydrogel comprises the steps:
步骤一、将靶标细胞游离DNA与锁式DNA探针、T4连接酶缓冲溶液经混合、孵育后,冷却至室温,得A处理液;
步骤二、在A处理液中加入T4连接酶,经培养、添加phi29 DNA聚合酶缓冲液、脱氧核糖核苷三磷酸和phi29 DNA聚合酶孵育后,再在50-60℃下加热25-35min,得B处理液;Step 2: Add T4 ligase to the A treatment solution, after culturing, adding phi29 DNA polymerase buffer, deoxyribonucleoside triphosphate and phi29 DNA polymerase for incubation, and then heating at 50-60 ° C for 25-35min, get B treatment solution;
步骤三、在B处理液中加入90-100μM血红素和20-25mM磷酸缓冲液的混合液,3-6℃条件下放置5-7h,之后用磷酸盐缓冲液对载血红素的DNA水凝胶进行冲洗,即得具有微孔结构的DNAzyme水凝胶。Step 3. Add a mixture of 90-100μM heme and 20-25mM phosphate buffer to the treatment solution B, and place it at 3-6°C for 5-7h, and then use phosphate buffer to hydrocoagulate the heme-loaded DNA. The gel is washed to obtain a DNAzyme hydrogel with a microporous structure.
优选的,所述步骤一中孵育的温度为85-100℃,时间为8-12min。Preferably, the incubation temperature in the first step is 85-100° C., and the time is 8-12 min.
优选的,所述步骤二中培养的方法是在16℃下培养8-12h,再在65℃下加热8-12min。Preferably, the method for culturing in the second step is culturing at 16° C. for 8-12 hours, and then heating at 65° C. for 8-12 minutes.
本发明还提供一种细胞游离DNA检测系统,包括DNAzyme检测平台、设于检测平台上的细胞游离DNA检测试剂盒、智能手机、图像处理模块和拟合线性曲线处理模块,所述智能手机拍摄的图片导入图像处理模块,拟合线性曲线处理模块对图像处理模块处理后的数字信息进行线性拟合。The present invention also provides a cell-free DNA detection system, comprising a DNAzyme detection platform, a cell-free DNA detection kit set on the detection platform, a smart phone, an image processing module and a fitting linear curve processing module. The image is imported into the image processing module, and the fitting linear curve processing module performs linear fitting on the digital information processed by the image processing module.
所述检测平台的构建及检测方法如下:The construction and detection method of the detection platform are as follows:
(1)检测平台的制备及细胞游离DNA定性检测:如图1a所示:细胞游离DNA以锁式DNA探针为模板在T4连接酶、phi29 DNA聚合酶和脱氧核糖核苷三磷酸作用下,通过滚环扩增形成DNAzyme水凝胶,DNAzyme水凝胶中G四联体是脱氧核酶的一种,催化H2O2的同时将无色的2,2-偶氮-双(3-乙基苯并噻唑啉-6-磺酸)(ABTS2-)催化为绿色氧化产物ABTS-产生可见信号实现对细胞游离DNA的定性检测;(1) Preparation of the detection platform and qualitative detection of cell-free DNA: As shown in Figure 1a: cell-free DNA is treated with a padlock DNA probe as a template under the action of T4 ligase, phi29 DNA polymerase and deoxyribonucleoside triphosphate. DNAzyme hydrogel was formed by rolling circle amplification. The G-quadruplex in DNAzyme hydrogel is a kind of deoxyribozyme, which catalyzes H 2 O 2 and converts colorless 2,2-azo-bis(3- Ethylbenzothiazoline-6-sulfonic acid) (ABTS 2- ) catalyzes the green oxidation product ABTS- to generate visible signal to realize the qualitative detection of cell-free DNA;
(2)细胞游离DNA定量检测:如图1b所示将反应体系置入3D打印检测试剂盒(试剂盒实物如图1c)中,通过智能手机记录图像,并通过手机中的软件对信号分析得到相应的吸光值,进而建立定量关系实现对细胞游离DNA进行定量检测,其过程如图1d。本发明实现了不需要大型仪器就实现了对细胞游离DNA的现场检测和分析,具有携带方便、成本低廉、操作简单等优势。(2) Quantitative detection of cell-free DNA: As shown in Figure 1b, put the reaction system into the 3D printing detection kit (the actual kit is shown in Figure 1c), record the image through the smartphone, and analyze the signal through the software in the mobile phone. The corresponding absorbance value, and then establish a quantitative relationship to achieve quantitative detection of cell-free DNA, the process is shown in Figure 1d. The invention realizes the on-site detection and analysis of cell-free DNA without needing large-scale instruments, and has the advantages of convenient portability, low cost, simple operation and the like.
优选的,所述细胞游离DNA检测试剂盒为3D打印机制作的3D打印试剂盒,3D打印试剂盒内设有离心管、光源和用于放置于智能手机摄像头前的滤光片。Preferably, the cell-free DNA detection kit is a 3D printing kit made by a 3D printer, and the 3D printing kit is provided with a centrifuge tube, a light source and a filter for placing in front of a smartphone camera.
优选的,所述3D打印试剂盒的尺寸为150毫米×75毫米×30毫米,光源的尺寸为70毫米×30毫米;滤光片的尺寸为12毫米×12毫米。Preferably, the size of the 3D printing kit is 150 mm×75 mm×30 mm, the size of the light source is 70 mm×30 mm, and the size of the filter is 12 mm×12 mm.
优选的,所述拟合线性曲线处理模块为origin软件。Preferably, the fitting linear curve processing module is origin software.
本发明还提供所述细胞游离DNA检测系统的操作方法,包括如下步骤:The present invention also provides an operation method of the cell-free DNA detection system, comprising the following steps:
S1、制备DNAzyme水凝胶;S1, prepare DNAzyme hydrogel;
S2、在制备的DNAzyme水凝胶中加入1-2μM ABTS和3-5μM H2O2进行催化反应,之后将催化反应后的DNAzyme水凝胶放入3D打印试剂盒中,在光照条件下,用智能手机拍照记录不同细胞游离DNA浓度下对应溶液的不同颜色的图片;S2. Add 1-2 μM ABTS and 3-5 μM H 2 O 2 to the prepared DNAzyme hydrogel for catalytic reaction, and then put the catalytically reacted DNAzyme hydrogel into the 3D printing kit. Under the condition of light, Use a smartphone to take pictures to record the pictures of different colors of the corresponding solutions under different cell-free DNA concentrations;
S3、将智能手机拍摄的图片导入图像处理模块中,以将图像的颜色强度转换为数字信息;S3. Import the picture taken by the smartphone into the image processing module to convert the color intensity of the image into digital information;
S4、通过origin软件拟合线性标准曲线,得到的曲线中横坐标是细胞游离DNA浓度的对数,纵坐标是图像的颜色所对应的强度。S4. Fitting a linear standard curve by origin software, the abscissa in the obtained curve is the logarithm of the cell-free DNA concentration, and the ordinate is the intensity corresponding to the color of the image.
本发明机理:The mechanism of the present invention:
该试剂盒的载体为进行目标响应的水凝胶,细胞游离DNA以E542K为靶标首先触发滚环扩增生成宏观DNAzyme水凝胶,该水凝胶易于肉眼观察,便于定性检测。此外,DNAzyme水凝胶具有辣根过氧化物酶(HRP)催化功能,将无色的2,2-偶氮-双(3-乙基苯并噻唑啉-6-磺酸)(ABTS2-)催化为绿色氧化产物ABTS-产生可见信号,智能手机能对试剂盒中图像进行采集并分析,建立关系曲线实现对细胞游离DNA的定量检测,该发明能够对细胞游离DNA进行现场检测和分析,具有携带方便、成本低廉、操作简单等优势。The carrier of the kit is a target-responsive hydrogel. The cell-free DNA first triggers rolling circle amplification with E542K as the target to generate a macroscopic DNAzyme hydrogel. The hydrogel is easy to observe with the naked eye and facilitate qualitative detection. In addition, DNAzyme hydrogel has horseradish peroxidase (HRP) catalytic function, which converts colorless 2,2-azo-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS 2- ) catalyzes the green oxidation product ABTS - to generate a visible signal, the smart phone can collect and analyze the images in the kit, and establish a relationship curve to realize the quantitative detection of cell-free DNA. The invention can carry out on-site detection and analysis of cell-free DNA, It has the advantages of convenient portability, low cost and simple operation.
本发明的有益效果:Beneficial effects of the present invention:
在本发明中,所述细胞游离DNA检测的模型靶点为E542K,E542K是PIK3CA基因的一个热点突变,广泛存在于乳腺癌、胃癌、肺癌和脑癌中。In the present invention, the model target for cell-free DNA detection is E542K, which is a hot spot mutation of the PIK3CA gene and widely exists in breast cancer, gastric cancer, lung cancer and brain cancer.
本发明设计的DNAzyme水凝胶,细胞游离DNA检测试剂盒,可用于检测人血清中的细胞游离DNA,该平台具有良好的灵敏度和回收率,并且可以进行现场测试,本方法基于智能手机的便携式平台的可用性为资源有限的领域提供了一个新的有前景的诊断工具,并且操作简单、检测时间短、节省设备成本、无需大型仪器。The DNAzyme hydrogel and cell-free DNA detection kit designed in the present invention can be used to detect cell-free DNA in human serum. The platform has good sensitivity and recovery rate, and can be tested on-site. The method is based on a portable smart phone. The availability of the platform provides a new and promising diagnostic tool for resource-constrained fields, with simple operation, short detection time, equipment cost savings, and no need for large instrumentation.
附图说明Description of drawings
为了更清楚地说明本说明书一个或多个实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本说明书一个或多个实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate one or more embodiments of the present specification or the technical solutions in the prior art, the following briefly introduces the accompanying drawings used in the description of the embodiments or the prior art. Obviously, in the following description The accompanying drawings are only one or more embodiments of the present specification, and for those of ordinary skill in the art, other drawings can also be obtained from these drawings without any creative effort.
图1中a为DNAzyme水凝胶平台对细胞游离DNA(cfDNA)的检测示意图;b为3D打印试剂盒内部结构示意图;c为真实检测中的3D打印试剂盒照片;d为智能手机分析的流程;In Figure 1, a is a schematic diagram of the detection of cell-free DNA (cfDNA) by the DNAzyme hydrogel platform; b is a schematic diagram of the internal structure of the 3D printing kit; c is the photo of the 3D printing kit in the actual detection; d is the process of smartphone analysis ;
图2中a为基于智能手机DNAzyme水凝胶分析样品溶液的颜色强度,其中I为细胞游离DNA与锁式DNA探针滚环扩增后加入血红素和ABTS/H2O2;II为没有细胞游离DNA存在时,锁式DNA探针进行滚环扩增反应后加入血红素和ABTS/H2O2;III为血红素和ABTS/H2O2;IV为ABTS/H2O2;b为上述样品溶液的对应吸光度值曲线,并与a对应,细胞游离DNA、血红素、ABTS和H2O2的浓度分别为30nM、100μM、2mM和4mM;c中左边为脱氧核酶水凝胶在水中的照片,中间为20×SYBR Green I染色DNAzyme水凝胶在阳光下的照片,右边为在紫外灯下的图片;d为1μm尺度下DNAzyme水凝胶的SEM图像;In Figure 2, a is the color intensity of the sample solution based on smartphone DNAzyme hydrogel analysis, where I is the addition of heme and ABTS/H 2 O 2 after cell-free DNA and padlock DNA probe rolling circle amplification; II is no In the presence of cell-free DNA, heme and ABTS/H 2 O 2 are added to the padlock DNA probe after rolling circle amplification reaction; III is heme and ABTS/H 2 O 2 ; IV is ABTS/H 2 O 2 ; b is the corresponding absorbance value curve of the above sample solution, and corresponds to a. The concentrations of cell-free DNA, heme, ABTS and H 2 O 2 are 30 nM, 100 μM, 2 mM and 4 mM, respectively; the left side of c is the deoxyribozyme hydrogel The photo of the glue in water, the middle is the photo of 20×SYBR Green I stained DNAzyme hydrogel under sunlight, the right is the photo under UV light; d is the SEM image of DNAzyme hydrogel at 1 μm scale;
图3中a为智能手机采集样品的光学图像;b为智能手机分析样品的颜色强度与细胞游离DNA浓度的校准曲线;c为颜色强度与细胞游离DNA浓度对数之间的线性关系,范围从0.1pM~1500nM;In Figure 3, a is the optical image of the sample collected by the smartphone; b is the calibration curve of the color intensity of the sample analyzed by the smartphone and the cell-free DNA concentration; c is the linear relationship between the color intensity and the logarithm of the cell-free DNA concentration, ranging from 0.1pM~1500nM;
图4中a为基于智能手机的DNAzyme检测平台对细胞游离DNA检测的选择性;b为基于智能手机的DNAzyme检测平台对细胞游离DNA检测的抗干扰能力,a和b中检测的样品和浓度分别为细胞游离DNA浓度为30nM、非细胞游离DNA为300nM和所有干扰底物均为300nM,空白样为20mM磷酸盐缓冲液(pH=7.4);c为基于智能手机的DNAzyme平台在不同温度的稳定性;d为基于智能手机的DNAzyme平台在不同存储时间下的稳定性;In Figure 4, a is the selectivity of the smartphone-based DNAzyme detection platform for cell-free DNA detection; b is the anti-interference ability of the smartphone-based DNAzyme detection platform for the detection of cell-free DNA. The samples and concentrations detected in a and b are respectively is cell-free DNA concentration of 30 nM, non-cell-free DNA of 300 nM and all interfering substrates at 300 nM, blank is 20 mM phosphate buffer (pH=7.4); c is the stability of the smartphone-based DNAzyme platform at different temperatures d is the stability of the smartphone-based DNAzyme platform under different storage times;
图5中a为人体活检取样分析示意图;b为使用基于智能手机的DNAzyme水凝胶平台对胃癌患者和健康个体血浆中E542K的定量结果;c为传统液滴数字PCR(ddPCR)的定量结果。In Figure 5, a is a schematic diagram of human biopsy sampling analysis; b is the quantitative result of E542K in the plasma of gastric cancer patients and healthy individuals using a smartphone-based DNAzyme hydrogel platform; c is the quantitative result of traditional droplet digital PCR (ddPCR).
具体实施方式Detailed ways
为使本公开的目的、技术方案和优点更加清楚明白,以下结合具体实施例,对本公开进一步详细说明。In order to make the objectives, technical solutions and advantages of the present disclosure clearer, the present disclosure will be further described in detail below with reference to specific embodiments.
需要说明的是,除非另外定义,本说明书一个或多个实施例使用的技术术语或者科学术语应当为本公开所属领域内具有一般技能的人士所理解的通常意义。“包括”或者“包含”等类似的词语意指出现该词前面的元件或者物件涵盖出现在该词后面列举的元件或者物件及其等同,而不排除其他元件或者物件。It should be noted that, unless otherwise defined, the technical or scientific terms used in one or more embodiments of the present specification shall have the usual meanings understood by those with ordinary skill in the art to which this disclosure belongs. "Comprises" or "comprising" and similar words mean that the elements or things appearing before the word encompass the elements or things recited after the word and their equivalents, but do not exclude other elements or things.
本发明涉及的DNA水凝胶的制备方法包括如下步骤:The preparation method of the DNA hydrogel involved in the present invention comprises the following steps:
(1)0.5~0.8μM细胞游离DNA与0.2~0.5μM锁式DNA探针在T4连接酶缓冲溶液中混合,85~100℃孵育8~12min,然后冷却至室温。(1) Mix 0.5-0.8 μM cell-free DNA and 0.2-0.5 μM padlock DNA probe in T4 ligase buffer solution, incubate at 85-100°C for 8-12 min, and then cool to room temperature.
(2)在冷却溶液中加入10~15U/μL的T4连接酶,在16℃下培养8~12h,再在65℃下加热8~12min后加入phi29 DNA聚合酶缓冲液。(2) Add 10-15U/μL of T4 ligase to the cooling solution, incubate at 16°C for 8-12h, then heat at 65°C for 8-12min, and then add phi29 DNA polymerase buffer.
(3)8~12mM脱氧核糖核苷三磷酸和1~5U/μL phi29 DNA聚合酶在30℃下孵育20~24h,然后在50~60℃下加热25~35min。(3) 8~12mM deoxyribonucleoside triphosphate and 1~5U/μL phi29 DNA polymerase were incubated at 30℃ for 20~24h, and then heated at 50~60℃ for 25~35min.
(4)操作完成后,加入90~100μM血红素和20~25mM磷酸缓冲液(pH=7.4)混合溶液放置3~6℃中放置5~7h,最后用磷酸盐缓冲液对载血红素的DNA水凝胶进行两次冲洗,即可以得到具有微孔结构的三维宏观DNA水凝胶。下面通过具体的实例进行详细说明。(4) After the operation is completed, add a mixed solution of 90-100 μM heme and 20-25 mM phosphate buffer (pH=7.4) and place it at 3-6 °C for 5-7 hours. The hydrogel was washed twice to obtain a three-dimensional macroscopic DNA hydrogel with a microporous structure. The following is a detailed description through specific examples.
实施例1Example 1
DNAzyme水凝胶的制备方法包括如下步骤:The preparation method of DNAzyme hydrogel comprises the following steps:
(1)0.6μM细胞游离DNA与0.3μM锁式DNA探针在T4连接缓冲溶液酶中混合,90℃孵育10min,然后冷却至室温。(1) 0.6 μM cell-free DNA and 0.3 μM padlock DNA probe were mixed in T4 ligation buffer solution enzyme, incubated at 90°C for 10 min, and then cooled to room temperature.
(2)在冷却溶液中加入10U/μL的T4连接酶,在16℃下培养10h,再在65℃下加热10min后加入phi29 DNA聚合酶缓冲液。(2) 10U/μL of T4 ligase was added to the cooling solution, incubated at 16°C for 10h, heated at 65°C for 10min, and then added with phi29 DNA polymerase buffer.
(3)10mM脱氧核糖核苷三磷酸和2U/μL phi29 DNA聚合酶在30℃下孵育24h,然后在55℃下加热30min。(3) 10mM deoxyribonucleoside triphosphate and 2U/μL phi29 DNA polymerase were incubated at 30°C for 24h, and then heated at 55°C for 30min.
(4)操作完成后,加入100μM血红素和20mM磷酸缓冲液(pH=7.4)混合溶液放置4℃中放置6h,最后用磷酸盐缓冲液对载血红素的DNA水凝胶进行两次冲洗,即可以得到具有微孔结构的三维宏观DNAzyme水凝胶,其1μm尺度下SEM图像如图2d,所得DNAzyme水凝胶分析样品溶液颜色强度和对应吸光度值曲线如图2a和图2b所示;由三维宏观DNAzyme水凝胶构成的DNAzyme检测平台对细胞游离DNA检测的选择性、抗干扰性级不同温度和存储时间下的稳定性如图4所示。(4) After the operation is completed, add a mixed solution of 100 μM heme and 20 mM phosphate buffer (pH=7.4) and place it at 4°C for 6 hours. Finally, the heme-loaded DNA hydrogel is washed twice with phosphate buffer. That is, a three-dimensional macroscopic DNAzyme hydrogel with a microporous structure can be obtained. The SEM image of the 1 μm scale is shown in Figure 2d. The obtained DNAzyme hydrogel analysis sample solution color intensity and corresponding absorbance value curve are shown in Figure 2a and Figure 2b; Figure 4 shows the selectivity and anti-interference level of DNAzyme detection platform composed of three-dimensional macroscopic DNAzyme hydrogel for cell-free DNA detection at different temperatures and storage times.
智能手机获取图像Smartphone to acquire image
加入2μM ABTS和4μM H2O2进行催化反应,将水凝胶放入3D打印试剂盒中,在普通光源提供光照条件下,用智能手机拍照记录下不同细胞游离DNA浓度下对应的试剂盒中溶液不同颜色的图片,可以观察到,随着细胞游离DNA浓度的增加获取到图片上不同试剂盒颜色逐渐变深,结果如图3a所示。2μM ABTS and 4μM H 2 O 2 were added to catalyze the reaction, and the hydrogel was placed in the 3D printing kit. Under the condition of light provided by a common light source, take pictures with a smartphone to record the corresponding kits under different cell-free DNA concentrations. For pictures of different colors of the solution, it can be observed that with the increase of cell-free DNA concentration, the colors of different kits on the pictures gradually become darker, and the results are shown in Figure 3a.
软件对图像的分析Analysis of the image by the software
(1)获取到的不同细胞游离DNA浓度下对应的图片,通过智能手机拍摄的图片导入Image J程序,点击Analyze→Gels→Plot lanes→Analyze→Measure,将试剂盒的图像的颜色强度转换为数字信息;(1) The obtained pictures corresponding to different cell-free DNA concentrations are imported into the Image J program through the pictures taken by the smartphone, and click Analyze→Gels→Plot lanes→Analyze→Measure to convert the color intensity of the image of the kit to a number information;
(2)通过origin软件拟合线性标准曲线,如图3c所示得到的曲线中横坐标是细胞游离DNA浓度的对数,纵坐标是试剂盒颜色所对应的强度。(2) Fitting a linear standard curve by origin software, in the curve obtained as shown in Figure 3c, the abscissa is the logarithm of the cell-free DNA concentration, and the ordinate is the intensity corresponding to the color of the kit.
真实样本中细胞游离DNA的检测(具体流程如图5a)Detection of cell-free DNA in real samples (the specific process is shown in Figure 5a)
人血清样品首先以1:10稀释,然后加入5pM、10pM和50pM浓度的细胞游离DNA进行检测。利用本发明开发的检测平台进行检测得到人血清中细胞游离DNA的浓度并计算和细胞游离DNA的回收率,数据如表1所示。检测结果与添加浓度一致。三组样本的相对标准偏差(RSD)均小于7%。加样回收率为96.8%~104.2%,符合分析要求。基于加标血清样本实验获得的预期结果,我们测试了直接测定胃癌患者血浆中E542K的测量性能,作为癌症诊断的真正应用。患者组(30.72 37.14ng/mL,重复分析n=4)和健康组(6.22 7.39ng/mL)也可以被显著区分,定量结果如图5b,并且与图5c中传统液滴数字PCR(ddPCR)定量结果比较可以看出本方法在实际样品检测中具有足够的准确性和重现性。Human serum samples were first diluted 1:10 and then assayed by addition of cell-free DNA at concentrations of 5pM, 10pM and 50pM. The detection platform developed by the present invention is used to detect the concentration of cell-free DNA in human serum and calculate the recovery rate of cell-free DNA. The data are shown in Table 1. The detection results were consistent with the added concentration. The relative standard deviation (RSD) of the three groups of samples were all less than 7%. The recovery rate of sample addition was 96.8%~104.2%, which met the analysis requirements. Based on the expected results obtained from experiments with spiked serum samples, we tested the measurement performance for the direct determination of E542K in the plasma of gastric cancer patients as a real application in cancer diagnosis. The patient group (30.72 ± 37.14 ng/mL, repeated analysis n = 4) and the healthy group (6.22 ± 7.39 ng/mL) could also be significantly differentiated, and the quantitative results are shown in Figure 5b, and are consistent with traditional droplet digital PCR (ddPCR) in Figure 5c Comparison of quantitative results shows that this method has sufficient accuracy and reproducibility in actual sample detection.
表1Table 1
所属领域的普通技术人员应当理解:以上任何实施例的讨论仅为示例性的,并非旨在暗示本公开的范围(包括权利要求)被限于这些例子;在本公开的思路下,以上实施例或者不同实施例中的技术特征之间也可以进行组合,步骤可以以任意顺序实现,并存在如上所述的本说明书一个或多个实施例的不同方面的许多其它变化,为了简明它们没有在细节中提供。Those of ordinary skill in the art should understand that the discussion of any of the above embodiments is only exemplary, and is not intended to imply that the scope of the present disclosure (including the claims) is limited to these examples; under the spirit of the present disclosure, the above embodiments or Technical features in different embodiments may also be combined, steps may be implemented in any order, and there are many other variations of the different aspects of one or more embodiments of this specification as described above, which are not in detail for the sake of brevity supply.
本说明书一个或多个实施例旨在涵盖落入所附权利要求的宽泛范围之内的所有这样的替换、修改和变型。因此,凡在本发明的精神和原则之内,所做的任何省略、修改、等同替换、改进等,均应包含在本公开的保护范围之内。The embodiment or embodiments of this specification are intended to cover all such alternatives, modifications and variations that fall within the broad scope of the appended claims. Therefore, any omission, modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention should be included within the protection scope of the present disclosure.
序列表sequence listing
<110> 安庆师范大学<110> Anqing Normal University
<120> 一种细胞游离DNA检测试剂盒、检测系统及操作方法<120> A cell-free DNA detection kit, detection system and operation method
<130> 1<130> 1
<141> 2022-01-14<141> 2022-01-14
<160> 1<160> 1
<170> SIPOSequenceListing 1.0<170> SIPOSequenceListing 1.0
<210> 1<210> 1
<211> 40<211> 40
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence
<400> 1<400> 1
ttagagagta tttttttttt tccccctttt ttcagtgatt 40ttagagagta tttttttttt tccccctttt ttcagtgatt 40
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210042210.1A CN114369643A (en) | 2022-01-14 | 2022-01-14 | Cell-free DNA detection kit, detection system and operation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210042210.1A CN114369643A (en) | 2022-01-14 | 2022-01-14 | Cell-free DNA detection kit, detection system and operation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114369643A true CN114369643A (en) | 2022-04-19 |
Family
ID=81144853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210042210.1A Pending CN114369643A (en) | 2022-01-14 | 2022-01-14 | Cell-free DNA detection kit, detection system and operation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114369643A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107557459A (en) * | 2017-09-29 | 2018-01-09 | 沈阳药科大学 | A kind of method that DNA hydrogels and DNAzyme detections SNP is used in combination |
CN112063691A (en) * | 2020-09-18 | 2020-12-11 | 湖北医药学院 | Method for detecting single-chain target nucleic acid sequence based on G4-heme DNase system |
-
2022
- 2022-01-14 CN CN202210042210.1A patent/CN114369643A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107557459A (en) * | 2017-09-29 | 2018-01-09 | 沈阳药科大学 | A kind of method that DNA hydrogels and DNAzyme detections SNP is used in combination |
CN112063691A (en) * | 2020-09-18 | 2020-12-11 | 湖北医药学院 | Method for detecting single-chain target nucleic acid sequence based on G4-heme DNase system |
Non-Patent Citations (5)
Title |
---|
SHAOWEI LIU ET AL.: ""Smartphone-Based Pure DNAzyme Hydrogel Platform for Visible and Portable Colorimetric Detection of Cell-Free DNA"", 《ACS SENS.》, vol. 7, pages 658 - 665 * |
XIAOXIA MAO ET AL.: "" Fabrication of DNAzyme-functionalized hydrogel and its application for visible detection of circulating tumor DNA"", 《SENSORS AND ACTUATORS B: CHEMICAL》, vol. 285, pages 385 - 390 * |
XIAOXIA MAO ET AL.: ""Fabrication of DNAzyme-functionalized hydrogel and its application for visible detection of circulating tumor DNA"", 《SENSORS AND ACTUATORS B: CHEMICAL》, vol. 285, pages 385 - 390 * |
ZHANMIN LIU ET AL.: ""Amplified visual detection of microRNA-378 through a T4 DNA ligase-mediated circular template specific to target and target-triggering rolling circle amplification"", 《ANAL.METHODS》, vol. 11, pages 2082 - 2088 * |
毛晓霞: ""新型DNA水凝胶的制备及其在生化分析中的应用"", 《中国优秀硕士学位论文全文数据库 工程科技I辑》, no. 2, pages 1 - 134 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xiong et al. | DNA walker-powered ratiometric SERS cytosensor of circulating tumor cells with single-cell sensitivity | |
WO2020253464A1 (en) | Nucleic acid quantitative analysis method based on intelligent device assistance and applications thereof | |
CN107340389A (en) | Method based on nucleic acid chromatography biosensor technique detection salmonella | |
Lin et al. | A novel urine analysis technique combining affinity chromatography with Au nanoparticle based surface enhanced Raman spectroscopy for potential applications in non‐invasive cancer screening | |
Zou et al. | Optical fiber amplifier and thermometer assisted point-of-care biosensor for detection of cancerous exosomes | |
Ge et al. | Pump-free microfluidic chip based laryngeal squamous cell carcinoma-related microRNAs detection through the combination of surface-enhanced Raman scattering techniques and catalytic hairpin assembly amplification | |
AU2010365277B2 (en) | Method for the diagnosis of a carcinoma and uses thereof | |
CN107365836A (en) | Method based on nucleic acid chromatography biosensor technique detection Bacillus cereus | |
CN101995462A (en) | Preparation and application of label-type electrochemical immunosensor for detecting veterinary drug residues | |
CN101949926A (en) | Human echinococcosis colloidal gold immunochromatographic assay urine testing quick diagnosis test paper card | |
Yang et al. | NAD (P) H activated fluorescent probe for rapid intraoperative pathological diagnosis and tumor histological grading | |
CN114002213B (en) | Application of Cu/Au/Pt-MOFs and visual test paper thereof in detection of H2O2, Cys or glucose | |
CN109557060B (en) | Based on NH2Method for visually detecting alkaline phosphatase activity in serum by using (E) -Cu-MOF | |
Chen et al. | Structured protein probes modified with selenium nanoparticle for 1-minute measurement of SARS-CoV-2 antigen | |
CN115109859A (en) | A kind of multimodal composite function Helicobacter pylori nucleic acid detection test paper | |
CN114369643A (en) | Cell-free DNA detection kit, detection system and operation method | |
CN112730367B (en) | A method and device for the determination of alkaline phosphatase by a multi-signal spectral sensing platform based on a portable intelligent terminal | |
Zhu et al. | SERS microfluidic chip integrated with double amplified signal off-on strategy for detection of microRNA in NSCLC | |
Lu et al. | An enzymatic reaction-based SERS saliva analysis microporous array chip for chiral differentiation and high-throughput detection of D-amino acids | |
CN102346184B (en) | Novel application of Spondin-2 (SPON2) | |
Zhang et al. | An Injection Molded SlipChip with Self‐Sampling for Integrated Point‐of‐Care Testing of Human Papilloma Virus | |
Shen et al. | A dual-amplification strategy-intergated SERS biosensor for ultrasensitive hepatocellular carcinoma-related telomerase activity detection | |
CN110042145B (en) | A paper chip based on quantum dots and its preparation method and application in detecting glucose | |
Chen et al. | [Retracted] Application of Isothermal Signal Amplification Technique in the Etiological Diagnosis of Gonorrhea and Drug Resistance Gene Detection | |
Mohammadzadeh et al. | Methanobrevibacter smithii associates with colorectal cancer through trophic control of the cancer bacteriome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |